In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Neuralstem, Inc.. Trade Record

NASDAQ:CUR Neuralstem, Inc. stock gains 8.90% Exit Jun 12, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart CUR May 31, 2017, priceSeries
About Neuralstem, Inc.

Neuralstem, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of central nervous system therapies based on its proprietary human neuronal stem cells and stem-cell derived small molecule compounds. The company's stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons of various types. Its clinical development products include NSI-189, which has completed Phase I clinical trial for the treatment of major depressive disorder, as well as is in Phase I clinical trial for the treatment of other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy; and NSI566 that has completed Phase II clinical trial for treating amyotrophic lateral sclerosis disease, as well as is in Phase I clinical trials for the treatment of chronic spinal cord injury and motor deficits due to ischemic stroke. The company was founded in 1996 and is headquartered in Germantown, Maryland.

Trade Information
Trade Type
LONG
ReliabilityScore™
93.44
Entry Date
May 31, 2017
Entry Price
89.20
Sell Date
Jun 12, 2017
Sell Price
97.14
Net Gain
8.90%
Hold Time
8 Trading Days